Synopsis
Although it has been described
that cerebral blood flow and cortical excitability is altered in migraineurs,
it is unknown if these processes may be differentially involved in chronic and
episodic forms of the disease. We used arterial spin labeling MRI und magnetic resonance
spectroscopy (GABA-editing) to address this problem. We found lower levels of
combined glutamate and glutamine in chronic and episodic migraineurs relative
to controls. Chronic patients showed hypoperfusion relative to controls and
episodic migraineurs. Our results might indicate severe signs of cortical spreading
depression in chronic migraineurs. The MRS findings suggest a disturbed
excitation-inhibition balance in migraineurs.Audience
People that are interested in metabolic changes
in migraine
Introduction
Based on the available literature
1-3, altered cerebral blood flow (CBF) has been
observed during migraine attacks and changes in cortical excitability have been
described. Yet, it is unknown if these processes may be differentially involved
in chronic and episodic forms of the disease.
Methods
We examined 16 adult patients with episodic (EM, 2
males) and 21 with chronic migraine (CM, 6 males) as well as 26 healthy controls
(HC, 10 males). We recorded attack
frequency, pain intensity, aura occurrence and medication. To
assess baseline CBF (during the interictal
period), we used non-invasive arterial spin labeling magnetic resonance imaging
(ASL-MRI). Specifically, CBF was recorded with a 2D pseudo-continuous ASL
(pCASL) sequence
4 with background
suppression (repetition time (TR)/echo time (TE) = 4200/16 ms, flip angle: 90°,
voxel size: 3 x 3 mm, 20 slices, thickness: 6 mm, labeling duration: 1.65 s,
post-labeling delay: 1.53 s) implemented on a Philips 3 Tesla Ingenia scanner. Equilibrium
brain tissue magnetization (M0) images
were recorded too. The ASL analysis was performed with the ASL toolbox
5. Pre-processing included
motion correction, spatial smoothing and normalization. CBF quantification was
done using the one-compartment model
6. CBF difference images were achieved by simple subtraction
to minimize spurious BOLD contaminations within the CBF signal
7. We assessed main effects
of group with an analysis of variance (ANOVA). Next, we calculated planned
contrasts (t-tests, p < 0.001)
between groups. For magnetic resonance spectroscopy (MRS) imaging, we used
MEGA-PRESS
8, 9 to asses both GABA (inhibition) and Glx
(combined glutamate and glutamine: excitation). MEGA editing was combined with
the Point-Resolved Spectroscopy Sequence, inner volume saturation (Henning et
al., 2008), and interleaved “VAPOR” water suppression
10, 11. MEGA-PRESS with inner volume saturation
increases sensitivity for edited single-voxel measurements of glutamate and
GABA
8. We recorded ten blocks (320
averages total) and per block, the editing pulse was applied in an alternating
manner either at 1.9 ppm or at 7.5 ppm. All blocks were retrospectively
frequency aligned using the Choline and Creatine as frequency references. The
radio frequency carrier frequency was set to Creatine. MRS parameters were: TR/TE:
1800 ms/68 ms, editing pulse duration: 16 ms. We recorded MRS from a voxel
covering the bilateral visual cortex (30 x 30 x 30 mm), positioned on a
T1-weighted 3D-MPRAGE image. The analysis was performed with TARQUIN (Wilson et
al., 2011) that yields comparable reliability in metabolite concentration
estimates to LCModel
12-14. Spectral quality was assessed using Cramer-Rao
lower bounds (CRLB); data with a CRLB > 20% were considered unreliable. The
reference signal was set to H2O (= H2O scaled).
Metabolite-to-H2O ratios were corrected for differences in grey- and
white matter, and cerebrospinal fluid voxel content, influencing the measured H2O
concentration
15. The resulting
metabolite-to-H2O ratios are presented in institutional units (IU).
Results
Participants did not differ with respect to sex, age, and handedness. Pain
scores (during MRI), depression and anxiety values were not different between
the two patient groups. For CBF, a main effect of group was seen (
F(3, 60) = 8.4,
p < 0.001). EM revealed lower CBF
than HC in fronto-central brain regions, including the striatum (Fig. 1A). In
contrast, EM showed stronger CBF in the brainstem (Fig. 1B). The contrast ‘HC -
CM’ yielded widespread hypoperfusion in frontal, somatosensory, parietal,
temporal, cerebellar, and visual regions in CM (Fig 1C). EM demonstrated higher
CBF than CM in visual, parietal, thalamic, cerebellar, temporal, orbito- and inferior
frontal regions (Fig. 1D). Glx was reduced in CM (
p = 0.002) and EM (
p =
0.036) relative to HC (Figure 2). GABA was higher in the EM than CM group (
p = 0.041). Headache days were not
linked to levels of GABA or Glx within or across patient groups.
Discussion
and Conclusion
CBF changes in migraineurs are observable in areas
linked to pain processing such as the anterior cingulate and insular cortex,
thalamus, and brainstem. CM showed even lower CBF relative to EM in visual areas, which
might be linked to more severe signs of cortical spreading depression in
chronically affected patients. Based on the MRS findings, we conclude that cortical
excitability is altered during interictal periods in EM and CM, and that the excitation-inhibition
balance is especially disturbed in CM, as not only Glx but also
GABA is altered. However, it needs to be
examined if it is glutamine and/or glutamate that are lowered in migraineurs.
Acknowledgements
We thank the Hansruedi Isler foundation for financial support.References
1. Aguila, M.E., et al. Elevated levels of GABA+ in migraine detected using (1)
H-MRS. NMR in biomedicine 28, 890-897 (2015).
2. Pollock, J.M., et al.
Migraine associated cerebral hyperperfusion with arterial spin-labeled MR
imaging. AJNR. American journal of
neuroradiology 29, 1494-1497
(2008).
3. May, A. New insights into headache: an update on functional
and structural imaging findings. Nature
reviews. Neurology 5, 199-209
(2009).
4. Wong, E.C., Buxton, R.B. & Frank, L.R. Implementation of
quantitative perfusion imaging techniques for functional brain mapping using
pulsed arterial spin labeling. NMR in
biomedicine 10, 237-249 (1997).
5. Wang, Z., et al.
Empirical optimization of ASL data analysis using an ASL data processing
toolbox: ASLtbx. Magn Reson Imaging 26, 261-269 (2008).
6. Buxton, R.B., et al.
A general kinetic model for quantitative perfusion imaging with arterial spin
labeling. Magnetic resonance in medicine
: official journal of the Society of Magnetic Resonance in Medicine / Society
of Magnetic Resonance in Medicine 40,
383-396 (1998).
7. Liu, T.T. & Wong, E.C. A signal processing model for
arterial spin labeling functional MRI. Neuroimage
24, 207-215 (2005).
8. Edden, R.A. & Barker, P.B. Spatial effects in the
detection of gamma-aminobutyric acid: improved sensitivity at high fields using
inner volume saturation. Magn Reson Med 58, 1276-1282 (2007).
9. Puts, N.A. & Edden, R.A. In vivo magnetic resonance
spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc 60,
29-41 (2012).
10. Hock, A., Fuchs, A., Boesiger, P., Kollias, S.S. &
Henning, A. Electrocardiogram-triggered, higher order, projection-based B(0)
shimming allows for fast and reproducible shim convergence in spinal cord (1)H
MRS. NMR in biomedicine 26, 329-335 (2013).
11. Tkac, I., Starcuk, Z., Choi, I.Y. & Gruetter, R. In vivo
1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 41,
649-656 (1999).
12. Mullins, P.G., et al.
Current practice in the use of MEGA-PRESS spectroscopy for the detection of
GABA. NeuroImage 86, 43-52 (2014).
13. Provencher, S.W. Estimation of metabolite concentrations from
localized in vivo proton NMR spectra. Magn
Reson Med 30, 672-679 (1993).
14. Wilson, M., Reynolds, G., Kauppinen, R.A., Arvanitis, T.N.
& Peet, A.C. A constrained least-squares approach to the automated
quantitation of in vivo (1)H magnetic resonance spectroscopy data. Magn Reson Med 65, 1-12 (2011).
15. Gasparovic, C., et al.
Use of tissue water as a concentration reference for proton spectroscopic imaging.
Magn Reson Med 55, 1219-1226 (2006).